You have done the reading. You know you want a branded medication such as Wegovy or Zepbound, you have decided you will not inject a vial mixed by a compounding pharmacy, and you would like a licensed clinician to write the order so you can get back to your week. So the question is a fair one: why pay a membership for a GLP-1 prescription when the prescription is the only thing you came for?
This piece answers that question for one kind of reader: someone who wants branded medication, a clinician who knows their history, and real numbers to judge progress by, and who is used to paying for quality when the quality is real. The answer comes in three steps: what a GLP-1 prescription actually sets in motion, how every company that writes one gets paid, and what GoodLife Health's $299 a month does and does not include. GoodLife Health sells the membership, so we have a stake in the answer. Read with that in mind; every price below carries its source and its date. If you would rather know first whether you qualify, the eligibility check is the first step for every patient.
- A GLP-1 prescription starts months of clinical decisions, and every company that writes one is paid for that work somewhere.
- Some companies earn on the medication, some on insurance billing, and GoodLife Health on one flat fee.
- The $299 monthly fee covers clinicians licensed in all fifty states, four lab panels a year, messaging and video visits.
- Medication is filled by the pharmacy you choose at its own price, and GoodLife Health takes nothing on it.
- The membership pairs with insurance and does not replace it; coverage of any medication is never promised.
- If the cheapest possible prescription is the goal, this is the wrong membership.
What you are really asking for
The request sounds simple. You want a prescription, filled with a product made by the company that invented it, and you want it without a subscription you do not need. Much of what you have seen online seems to agree with you. Advertisements promise a prescription after a short questionnaire, a low monthly fee and a box at the door. The lowest prices tend to belong to compounded medication, which you have already ruled out, and the offers built on branded medication do not always show the full cost in one place.
You also know the medication itself costs real money. As published by the manufacturers in September 2026, NovoCare lists Wegovy pens at $199 a month for the first two fills, an introductory offer for new patients that runs through December 2026, and $349 a month after that, with the Wegovy pill from $149 a month at lower doses. LillyDirect lists Zepbound vials at $299 to $449 a month depending on dose. Put a $299 monthly membership next to those figures and it can look like paying twice for one thing.
Then there is your time. You are not looking for a standing appointment that eats an afternoon, and you do not want to explain your history to a different person every time something comes up. You already pay for an accountant who knows your situation, or a trainer who knows your shoulder, because what they know about you saves you trouble later. What you want to find out is whether this membership is that kind of purchase, or a toll booth set in front of a prescription you could get somewhere else.
That is the right question, and it deserves a straight answer.
What a GLP-1 prescription sets in motion, and who pays for it
The first thing worth seeing is that a GLP-1 prescription begins a course of treatment that runs for months. The dose is not fixed for the life of the treatment, which is why LillyDirect's own price list runs by dose. Each change is a clinical decision: whether to go up, hold or come down, based on how you are tolerating the medication and what your labs show. Side effects need someone to answer them, and results need someone to read them. Our guide to what a direct primary care membership includes puts it plainly: protocols for Wegovy and Zepbound require ongoing clinical judgment, with the clinician adjusting the dosing protocol based on your labs and your response.
That judgment is the work, and someone is paid for the time it takes, whatever the offer is called.
Our white paper, How GLP-1 Telehealth Companies Make Money, found that every telehealth company prescribing these medicines is paid in one of three ways, or a mix of them. The model is rarely on the homepage, but it is always on the pricing page if you know what to look for.
Three ways a GLP-1 telehealth company gets paid
| Model | Who pays the company | What the company is rewarded for |
|---|---|---|
| Margin on the medication | You, through a marked-up medication price | More medication sold through the company |
| Low fee plus insurance billing | You and your insurance plan | Care that fits what the plan reimburses |
| One flat fee, medication at the pharmacy's price | You, through the membership only | The care itself, at the same fee whatever is prescribed |
In the first model, the membership fee looks small and the medication costs more than it would at a pharmacy; the difference is the company's profit. The white paper's comparison chart, compiled from public pricing pages in May 2026, found branded tirzepatide offered through some legacy telehealth memberships at prices well above Lilly's own self-pay price. In the second model, the fee is low and the company bills your insurance, so part of its income depends on what your plan pays. In the third, you pay one flat fee for the care, the medication is filled at the pharmacy's own price, and the company takes no share of it.
None of these models makes a clinician good or bad. The white paper's point is narrower and more useful: the way a company gets paid is the pressure its clinicians work under, and it decides what the company is rewarded for. A company that earns on the medication is rewarded when more medication moves through it. A company that earns on claims is rewarded when the care fits what insurance reimburses. Neither pressure means anyone acts badly. It does mean you should know which one is in the room when a decision about your treatment is made.
Every prescription is paid for by someone; the useful question is whether you can see who.
This is the part of your question that changes the answer. Every prescription is paid for by someone; the useful question is whether you can see who. When the visit costs little, the money comes from the medication or from the claim. A low fee for the prescription is a price for one piece of the work, with the rest paid in a place you cannot see.
The second thing worth seeing is what "a clinician who knows you" means in practice. GoodLife Health is clinician-led precision direct primary care for Cardiometabolic Optimization, and the order is fixed: diagnosis first, then treatment, then the long haul. Before a GLP-1 is considered, the clinician wants your labs. The direct primary care guide lists fasting glucose, HbA1c, a lipid panel and liver enzymes as standard before a GLP-1 is started, and those numbers are part of deciding whether a medication is right for you at all.
Fasting glucose, HbA1c, a lipid panel and liver enzymes are standard before a GLP-1 is started. Repeating a panel every quarter lets each dose decision be read against the patient's own numbers.
You said you want the data. Quarterly labs give you that: four panels a year, with every result in your hands, so you and your clinician can judge each decision against your own numbers rather than against a questionnaire filled in once at the start. The same record follows you from month to month and from one decision to the next, which is what lets a clinician know you instead of meeting you again each time.
You have already decided against compounded vials, and nothing here asks you to reconsider. For the record, the facts are dated. The FDA declared the tirzepatide shortage resolved in December 2024 and the semaglutide shortage resolved in February 2025, and the last enforcement grace periods for compounding closed in spring 2025. The FDA has published its concerns about unapproved GLP-1 drugs used for weight loss, and both manufacturers have sued companies selling compounded versions. GoodLife Health does not prescribe compounded GLP-1, ever. That choice has a cost, and members carry it: the branded price is higher. A clinician's license carries the responsibility for what is prescribed, and ours prescribe branded, FDA-approved medication only.
What $299 a month covers, and what it does not
The membership is $299 a month, month to month. Here is everything that fee pays for:
- Clinicians licensed in all fifty states.
- Four cardiometabolic lab panels a year, a Biomarker Audit every 90 days.
- Every result in your hands.
- Asynchronous messaging with the care team, so a question about a side effect can be sent when it comes up instead of waiting for an appointment.
- Video visits.
The fee is the same whatever medication is indicated and whatever the dose. We call this Medication-Neutral Pricing: there is no molecule upcharge and no dose upcharge. If your clinician moves you from one branded medication to another, or changes your dose, the membership stays the same. That matters for the pressure described above. The clinician has no financial reason to prefer one molecule over another, or a higher dose over a lower one, because GoodLife Health earns the same in every case.
Medication is unbundled. When a medication is clinically indicated, it is prescribed to the pharmacy you choose, at that pharmacy's own price. GoodLife Health sets nothing, sees nothing and takes nothing on medication. For GLP-1 treatment, that means branded, FDA-approved products: Wegovy, Zepbound, Mounjaro or Ozempic, whichever your clinician judges indicated. The manufacturers' published self-pay prices above are one reference point for what you would pay; the price at your pharmacy is the one that applies. If your quarterly labs raise a question beyond weight, such as your thyroid, the same clinician can prescribe thyroid medication where it is indicated, because the membership is primary care for your metabolic health as a whole.
You keep your insurance. The membership pairs with it for catastrophic coverage and does not replace it; what it replaces is your primary-care relationship. Whether your plan covers a GLP-1 is between you, your plan and your pharmacy, and we never promise coverage. Prior authorization, where a plan requires it, is the pharmacy's process. GoodLife Health does not run it and cannot speed it up or win it for you.
At sign-up, $598 is charged, which covers your first two months. If the clinician cannot accept you into care, the $598 is refunded in full. Once you are accepted, the first two months are non-refundable. Medication billed by a pharmacy follows that pharmacy's own return and refund policy. After the first two months, the membership continues month to month, and a full year of it is $3,588. The membership fee is generally eligible for HSA or FSA pre-tax dollars, which many professionals already set aside each year.
Not everyone is accepted. The path is the eligibility check, the intake, the checkout and then a clinician's review, and the clinician decides. That is the honest limit on your original request: the membership does not hand out a prescription because one was asked for. Sometimes the right answer is a different medication, a different dose or no GLP-1 at all, and a clinician who can say yes has to be free to say no.
The membership does not promise weight loss, a particular result or a particular medication. If you were hoping for a continuous glucose monitor as part of the data, it is not part of the model; the data here comes from the quarterly panels and from your clinician reading them with you. GoodLife Health sits deliberately between two familiar options, the concierge practice at $20,000 a year and the compounded app at $99 a month, and it is priced and built for the patient in between.
The straight answer to your question
If what you want is a single prescription and no one involved afterward, a membership is the wrong thing to buy, and we would rather tell you so now. That is rarely what GLP-1 treatment turns out to be. The decisions after the first prescription are where most of the clinical work sits, and they are paid for in every model. The difference is whether the payment arrives as a fee you can see, or as a share of a medication price or an insurance claim that you cannot.
For the reader this piece is written for, the trade looks like this. You pay $299 a month for clinicians licensed in all fifty states, four lab panels a year, messaging and video visits, and you pay the pharmacy's own price for branded medication, with nothing added by GoodLife Health. In return you get a clinician whose income does not depend on which medication you take or at what dose, a record of your own numbers every quarter, and one place to take your questions when they come up. If you value advice you can trust because you can see how the adviser is paid, that structure is the product.
Whether it is worth $3,588 a year is your decision. We have tried to put every part of the price in view so you can make it, and the white paper sets out the three models in more detail if you want to compare offers on your own terms.
Who this is not for
If your priority is the lowest possible monthly figure, a $99 compounded app costs less, and this membership will not compete with it on price. If you want a prescription without labs, or without a clinician who might decline to prescribe, you will find the process here slower than you would like. If you are looking for a guaranteed result, we do not offer one. If you want a concierge physician who sees you in person whenever you ask, that is a different service at a different price. If your insurance already covers a GLP-1 and you have a primary-care clinician who knows you, orders your labs and answers your messages, you may already have most of what this membership provides, and paying for it a second time would make little sense. And if you hope the membership will stand in for health insurance, it will not; it is designed to sit beside your plan.
Related Reading
- How GLP-1 Telehealth Companies Make Money: A Plain-Language Whitepaper
- What Does Direct Primary Care Include in 2026
References
- NovoCare Pharmacy — Wegovy self-pay pricing (Novo Nordisk). 2026. www.novocare.com/pharmacy/wegovy.html
- Zepbound Self Pay Journey Program — LillyDirect vial pricing (Eli Lilly). 2026. zepbound.lilly.com/savings
- FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss (U.S. Food and Drug Administration). 2025. www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss